Rad Net, Inc. RDNT
We take great care to ensure that the data presented and summarized in this overview for RadNet, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding RDNT
View all-
Black Rock Inc. New York, NY9.61MShares$696 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.35MShares$532 Million0.01% of portfolio
-
Beck Mack & Oliver LLC New York, NY3.2MShares$232 Million5.0% of portfolio
-
State Street Corp Boston, MA2.45MShares$177 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY1.81MShares$131 Million2.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.75MShares$127 Million0.03% of portfolio
-
Invesco Ltd. Atlanta, GA1.66MShares$120 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.56MShares$113 Million0.01% of portfolio
-
Jb Capital Partners LP Armonk, NY1.5MShares$109 Million20.47% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL1.28MShares$92.9 Million1.65% of portfolio
Latest Institutional Activity in RDNT
Top Purchases
Top Sells
About RDNT
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
Insider Transactions at RDNT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Mark Stolper EVP, Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
275
-0.34%
|
-
|
|
Dec 05
2024
|
Lawrence L Levitt Director |
SELL
Bona fide gift
|
Direct |
2,700
-1.56%
|
-
|
|
Dec 02
2024
|
Michael N Murdock EVP, Mergers and Acquisitions |
SELL
Bona fide gift
|
Direct |
5,000
-10.39%
|
-
|
|
Nov 25
2024
|
David Jeffrey Katz EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,300
-8.54%
|
$996,300
$81.72 P/Share
|
|
Nov 19
2024
|
Ranjan Jayanathan Chief Information Officer |
SELL
Open market or private sale
|
Direct |
38,557
-16.67%
|
$3,084,560
$80.0 P/Share
|
|
Oct 01
2024
|
Cornelis Wesdorp Pres & CEO, Digital Health |
BUY
Grant, award, or other acquisition
|
Direct |
60,995
+50.0%
|
-
|
|
Oct 01
2024
|
David Jeffrey Katz EVP and Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,188
+11.93%
|
$295,452
$29.44 P/Share
|
|
Sep 16
2024
|
Mital Patel EVP, Chief Admin Officer |
SELL
Bona fide gift
|
Direct |
400
-0.2%
|
-
|
|
Sep 13
2024
|
Howard G Berger President, CEO |
SELL
Bona fide gift
|
Direct |
190,000
-39.56%
|
-
|
|
Aug 21
2024
|
Michael N Murdock EVP, Mergers and Acquisitions |
SELL
Open market or private sale
|
Direct |
15,000
-8.48%
|
$930,000
$62.82 P/Share
|
|
Aug 15
2024
|
Howard G Berger President, CEO |
SELL
Bona fide gift
|
Direct |
60,000
-11.11%
|
-
|
|
Aug 15
2024
|
Howard G Berger President, CEO |
BUY
Other acquisition or disposition
|
Direct |
500,000
+48.07%
|
-
|
|
Aug 14
2024
|
David Jeffrey Katz EVP and Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
1,640
-2.46%
|
-
|
|
Jun 18
2024
|
Mital Patel EVP, Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
29,800
-12.85%
|
$1,758,200
$59.0 P/Share
|
|
Jun 18
2024
|
Gregory E. Spurlock Director |
SELL
Open market or private sale
|
Direct |
7,167
-73.45%
|
$422,853
$59.75 P/Share
|
|
Jun 17
2024
|
Mital Patel EVP, Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
10,200
-4.21%
|
$612,000
$60.0 P/Share
|
|
Jun 17
2024
|
Gregory E. Spurlock Director |
SELL
Open market or private sale
|
Direct |
7,167
-42.35%
|
$422,853
$59.75 P/Share
|
|
Jun 14
2024
|
Lawrence L Levitt Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.26%
|
$228,000
$57.77 P/Share
|
|
Jun 13
2024
|
Laura Pastre Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,591
+9.63%
|
-
|
|
Jun 13
2024
|
Lawrence L Levitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,591
+1.45%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 276K shares |
|---|---|
| Exercise of conversion of derivative security | 11.4K shares |
| Other acquisition or disposition | 500K shares |
| Bona fide gift | 266K shares |
|---|---|
| Open market or private sale | 350K shares |